
over 10 years ago // #innov8aid
The global health community has energetically invested in technologies to keep vaccines cold given the high ambient temperatures and unreliable access to electricity in developing countries, yet no vaccine products have so far been commercialized. The Gates Foundation conducted a study to define the real value of increasing vaccine thermostability, and the results were surprising.